Author: admin

Leader of the Australian Greens Adam Bandt MP has today called on the government to defer the looming cuts to JobKeeper and JobSeeker in light of the growing COVID outbreak in NSW.
The Coronavirus Supplement is due to drop $200 a month in just 10 days, before being entirely cancelled come March 31.
“With lockdowns and travel bans throwing the country’s Christmas plans into chaos, Scott Morrison must immediately ditch the looming cuts to JobSeeker and JobKeeper,” Mr Bandt said.
“This is no time for Scott Morrison to play Scrooge, cutting payments by $200 a month while people and businesses face an uncertain Christmas.
“Instead of going missing in action as the pandemic bites again, Scott Morrison should pull the levers he’s got and postpone the cuts to payments.
“Where the bloody hell is he?
“While we all hope that lockdowns in NSW will last for days, not weeks, millions of people have been struck with uncertainty over whether they’ll be able to pay the bills come New Year’s Eve.
“You can’t cut the coronavirus supplement while the pandemic is continuing. This $200 could mean the difference between having food on the table or going hungry, and between making rent or facing eviction when protections end.
“People across the country are staying home and shutting their doors to limit the spread of coronavirus, but Scott Morrison isn’t doing his bit. JobSeeker and JobKeeper shouldn’t have been cut during the Victorian lockdown, and they shouldn’t be dropped now either.
“With just 10 days before the coronavirus supplement comes crashing down, Scott Morrison needs to stop the drop. Cutting income supports is always cruel, but Scott Morrison has picked the worst possible time to do it.”

The release of a report planning for the end of coal by the right-leaning Blueprint Institute shows that all sides of politics were now calling for a managed transition out of coal, Leader of the Australian Greens Adam Bandt MP said.
“The time of coal is over and the time for clean energy has begun,” Mr Bandt said. “When even conservative think tanks are putting forward proposals to leave coal, you can tell this transition is unstoppable.
“A safe climate requires us to get out of coal by 2030, but how we do it matters. Germany was able to transition out of coal without a single worker forcibly losing their job, but a bad approach could put thousands out of work and see a few coal barons get massive taxpayer-funded payouts.
“We have to manage coal closures to look after workers and communities while ensuring a reliable energy system. If we leave it to the corporate boardrooms of coal companies, they will push for the lowest cost option and put profits ahead of the community.
“The Greens prefer a regulated closure of coal plants overseen by a national transition authority, but we’re up for a discussion about the best way to manage the change.
“The Greens welcome a discussion about a just transition out of coal, because by continuing to pretend fossil fuel use will continue for decades, the Coalition government and Labor Party are throwing coal communities on the scrapheap.
“In Australia, we have seen transition done badly, and we must avoid that with coal communities. In some previous industry closures without government transition support, only a third of the workforce found secure work, a third ended up in precarious insecure work and the last third never found ongoing employment ever again.
“Australia owes coal workers and communities a debt of thanks for helping power our country up to this point, and we owe them a planned transition out of coal with secure jobs in other industries.”

The Australian Government has released the findings of the independent review into COVID-19 outbreaks at two Victorian aged care facilities: Heritage Care’s Epping Gardens and St Basil’s Home for the Aged.
Minister for Health, Greg Hunt said the report underlined the critical elements that led to the tragic outbreaks at the height of the second wave of community transmission across Melbourne following the Victorian Hotel Quarantine failures as outlined in today’s Inquiry.
It highlights the vital role the Commonwealth played to support the residents, staff and management affected by the outbreaks and underlines the lessons from both incidents.
Forty-five residents at St Basil’s Home for the Aged and 38 residents at Heritage Care’s Epping Gardens passed away.
“In extending our sincere condolences to the families of those who died, this investigation serves as a platform for understanding and action,” Minister Hunt said.
“I would like to acknowledge the role of residents and families in the preparation of the report during what clearly has been a very difficult time.”
As part of the Government’s considerations, a briefing for families with the authors of the report has been arranged ahead of its release.
“The health and wellbeing of senior Australians – and the workers who care for them – is of the utmost importance to the Australian Government,” Minister Hunt said.
“We continue to work day and night to safeguard the most vulnerable in our community.”
Minister Colbeck said the Australian Government has been adapting the National Response Plan for COVID-19 in aged care since early 2020 and, with the aged care sector, state and territory governments and health authorities, incorporating lessons learned from Australia and other countries.
The review into the two Victorian outbreaks was commissioned to give a voice to those who were directly affected by the tragic events. Its authors are members of the AHPPC’s Aged Care Advisory Group (ACAG) and have been informing the Australian Government since the pandemic started on an ongoing basis.
“It’s important we understand what occurred and what can be learned to make sure we can prevent similar outbreaks now and into the future,” he said.
Both St Basil’s Home for the Aged and Heritage Care’s Epping Gardens remain subject to a Notice to Agree (NTA) issued by the Aged Care Quality and Safety Commission.
A Notice to Agree is a serious enforcement measure which, if ignored, can lead to the approval to provide Australian Government subsidies being revoked, and comes at a cost to the provider.
Minister Colbeck said establishing the Victorian Aged Care Response Centre (VACRC) and significant actions by the Commonwealth Government to support providers to respond to emergency event in aged care is acknowledged in this report.
At the height of the second wave in Victoria, advice from the VACRC, is that there were more than 7,000 aged care staff furloughed who had either contracted COVID-19 or were close contacts.
To find replacements for this many staff was a mammoth task.
During the outbreak, according to VACRC data, more than 36,000 shifts were filled by replacement staff.
“The coordinating role of the VACRC was found to be a major driver in facilitating effective interagency communications,” Minister Colbeck said.
On 21 August 2020, National Cabinet endorsed the Commonwealth, State and Territory Plan to Boost Aged Care Preparedness for a Rapid Emergency Response to COVID-19.
A key component of the plan is the establishment of Aged Care Emergency Response Operations Centres. Within each jurisdictions’ public health response structure, a dedicated aged care emergency response team has been established and key personnel identified at the state and Commonwealth level.
“All jurisdictions have provided assurances that their Aged Care Emergency Response Centres can be stood up within 48 hours,” Minister Colbeck said.
The Australian Government will continue to work collaboratively with the states, the aged care sector, and public health authorities, to adapt and refine the approach to outbreaks in six key areas:

• Leadership and management
• Communication
• Emergency planning and preparation
• Infection prevention and control capacity and capability
• Pathology testing
• Surge workforce.

The Australian Government has now invested $1.8 billion to support older Australians in aged care since the start of the pandemic. This includes $132.2 million in response to the Aged Care Royal Commission’s recommendations on COVID-19.
Minister Colbeck acknowledges the work of report authors Professor Lyn Gilbert and Adjunct Professor Alan Lilly and all of the people who have taken part or supported these independent reviews.
As members of ACAG, the desire of the authors was to ensure the key findings from their research could be incorporated directly into advice to the sector.
Having been closely considered by the AHPPC and ACAG, where it has not already occurred, key learnings of the review will be implemented.
Every age care provider and facility leader in Australia should read this report – it is a powerful additional source of advice and information.
The report on the independent reviews of COVID-19 outbreaks at Heritage Care’s Epping Gardens and St Basil’s Home for the Aged can be found here.
The release of the report may be confronting for anyone affected by the impact of the pandemic on Australia’s aged care sector. The following support is available:

• The Older Persons Advocacy Network can be reached on 1800 700 600
• The Australian Centre for Grief and Bereavement can be reached on 1800 22 22 00
• The Essential Network for health professionals– a website and mobile application by the Black Dog Institute available at blackdoginstitute.org.au/ten or via the Google Play and Apple Store
• Smiling Mind – a mobile application which offers practical tools to support good mental health during challenging times available via the Google Play and Apple Store.

Aged care workers can also access mental health supports available to all Australians including:

• Beyond Blue Coronavirus Mental Wellbeing Support Service which can be reached on 1800 512 348 or at coronavirus.beyondblue.org.au.
• Lifeline which can be reached on 13 11 14
• Head to Health – provides access to free and low cost digital and phone mental health services and supports, available at headtohealth.gov.au

The Government is responding to the independent regulatory decision of the TGA today with a range of measures to support the cessation of smoking, and to help prevent teenagers taking up pathways to smoking.
As noted in the TGA decision (https://www.tga.gov.au/scheduling-decision-final/notice-final-decision-amend-current-poisons-standard-nicotine), from 1 October 2021, consumers importing nicotine will require a doctor’s prescription to legally access nicotine e-cigarettes and liquid nicotine. Child resistant closures for liquid nicotine will also be mandatory.
The TGA’s decision follows extensive public consultation, and is consistent with the existing ban in all states and territories on the sale of nicotine e-cigarettes without a doctor’s prescription. This is an independent decision of Government, which is legally binding.
In response to today’s decision, the Government will be taking the following actions:

• The previously proposed Customs (Prohibited Imports) Regulations will not be proceeding due to the significant overlap with the TGA decision.
• In consultation with the RACGP, AMA and other medical experts, the Government will develop a Telehealth Smoking Cessation item that will be available 6 months prior to the 1 October implementation date.
  • As part of this work the Government will provide $1 million for an education campaign focussed on smoking cessation.

It is important to note that any doctor may currently prescribe nicotine containing e-cigarettes that can be used by consumers for personal importation. This is not widely understood, and it is an important matter of public information that over 30,000 GPs may currently, and in the future, prescribe nicotine-based e-cigarettes for smoking cessation.
Secondly, any of these GPs can also register with the TGA to become what is known as an ‘Authorised Prescriber’. A GP who is an Authorised Prescriber can issue prescriptions for e-cigarettes for dispensing at a local pharmacy as an alternate option to personal importation.
Nicotine containing e-cigarettes are currently illegal to sell in every State and Territory, and possession in all jurisdictions (except South Australia) is also illegal without a valid medical prescription. That means that there is a current situation that legally imported materials are then illegally possessed under state law. This decision will both reduce the risk of an on ramp for teenagers as highlighted by the delegate, while rectifying the issue of legal importation but illegal possession.
The TGA scheduling delegate’s reasons for the decision included, but were not limited to:

• The current available evidence does not support that e-cigarettes are a safer alternative to smoking cessation aids currently available.
  • There is also currently insufficient evidence to conclude whether e-cigarettes can benefit smokers in quitting.
• Risk of nicotine addiction for new or continuing users.
• The introduction of novel nicotine delivery system may have a negative impact on tobacco control and may re-normalise smoking.
• Exposure to nicotine in adolescents may have long-term consequences for brain development, potentially leading to learning and anxiety disorders.
• Unknown toxicity of long-term exposure to heated and inhaled chemicals.
• Risk of accidental exposure to children, particularly in relation to liquid nicotine.

The delegate outlined that restrictions on the availability of e-cigarettes are necessary to mitigate the potential uptake of smoking in young adults who would otherwise be at low risk of initiating nicotine addiction.
We have already seen rapid growth of youth uptake in vaping overseas and already emerging in Australia. Specifically:

• Between 2015 and 2019, current e-cigarette usage by U.S. youth increased by approximately 1,128,000 young people aged 14-19 years (71.9% increase). This has resulted in a total of over 4 million U.S high students currently using e-cigarettes.
• In Australia between 2016 and 2019, the number of current e-cigarette users aged 15-24 increased by approximately 72,000 (95.7% increase) for a total of approximately 147,000.
• In addition, recent research from the Australian National University has found e-cigarette users are three times more likely to take up traditional cigarette products.

In particular, the TGA delegate found:
I have considered the Irish HRB reports, which conclude that adolescents using e-cigarettes are between three to five times more at risk of future initiation of cigarette smoking when compared to those who have never smoked e-cigarettes.
The findings of the Irish HRB reports were consistent with the SCHEER report, which concluded that there is strong evidence that e-cigarettes are a gateway to smoking for young people. Similar conclusions were reached in the ANU report, which found that, across multiple settings, non-smokers who use e-cigarettes are consistently more likely than non-e-cigarettes users to initiate cigarette smoking.
I regard the reports of the Irish HRB, SCHEER and ANU to be independent, credible and relevant to my deliberations on nicotine addiction associated with e-cigarette use in adolescents. It follows that I have attached significant weight to these reports on the basis that these are current and comprehensive scientific reviews undertaken by leading international organisations. I note that the findings of the three reports are broadly consistent.
This can be characterised as seeking to avoid an ON RAMP for non-smokers, especially youth.
At the same time, today’s decision is designed to facilitate a simple and legal option to nicotine containing e-cigarettes for smoking cessation – to provide the OFF RAMP for smokers.
The RACGP smoking cessation guidelines stipulate that nicotine containing e-cigarettes are not first line treatment for smoking cessation. However, for people who have tried to achieve smoking cessation with approved pharmacotherapies but failed, and who are still motivated to quit smoking and have brought up e-cigarette usage with their healthcare practitioner, nicotine containing e-cigarettes may be a reasonable intervention to recommend.
Where appropriate, consumers will be able to continue using nicotine e-cigarettes as a smoking cessation aid based on their doctor’s advice. Consumers will be able to purchase nicotine e-cigarettes from overseas, online or from local pharmacies, with a prescription.
The decision also aligns with advice from Australia’s medical experts, including the National Health and Medical Research Council and Australian Health Protection Principal Committee (AHPPC), who have warned of the health dangers of e-cigarettes.
Around the world we have seen much evidence of young people being introduced to nicotine through vaping for the first time, and in July 2018, a Victorian toddler died from nicotine poisoning.
The former head of the Food and Drug Administration in the United States, Scott Gottlieb M.D, referred to use of e-cigarette use amongst American youth as an ‘epidemic’.
The Government supports the independence of the TGA in making decisions around medicine availability and the approval of medicines, medical devices and vaccines for supply to Australians based on expert health advice. Scheduling decisions of the TGA are not subject to disallowance either by the Parliament of the Minister.
The delegate also took into account the Senate Committee Report of 18 December 2020, in addition to international evidence. The decision includes a post-market review as recommended in the report, and follows majority support for the independent role of the TGA under its Act, and support for this course of action.

A significant lung cancer treatment option that costs approximately $88,000 a year will soon be available for as little as $6.60 per script, thanks to its expanded listing on the Pharmaceutical Benefits Scheme (PBS).
From 1 January 2021, Australians living with non-small cell lung cancer who have not had prior therapy will benefit from the listing of Tagrisso^® (osimertinib).
Without the PBS subsidy, patients might pay close to $8,000 per script or almost $88,000 per year for this treatment. An average of 1,120 patients per year could now pay as little as $41.30 per script, or $6.60 with a concession card.
Tagrisso^® is a ‘targeted therapy,’ which works on specific types of cancer cells where a specific mutation is present, to block the growth and spread of these cancer cells.
Following expert medical advice the Government is expanding access to this breakthrough medicine for the first-line treatment of patients with metastatic non-small cell lung cancer, who have a certain type of mutation in the lungs, known as Epidermal Growth Factor Receptor (EGFR) positive.
Tagrisso acts by blocking the activity of the EGFR, which causes growth and uncontrolled division of cancer cells.
An oral therapy, Tagrisso will help patients experience an improved quality of life, and see them able to access the treatment at home and not in the hospital.
The Australian Institute of Health and Welfare estimates that more than 13,000 new cases of lung cancer will be diagnosed in 2020. It is the fifth most common cancer diagnosed in Australia.
This listing has been recommended by the independent Pharmaceutical Benefits Advisory Committee (PBAC).
Since 2013, the Australian Government has approved more than 2,500 new or amended listings on the PBS.
This represents an average of around 30 listings or amendments per month – or one each day – at an overall investment by the Government of close to $12 billion.
The Government’s commitment to ensuring Australians can access affordable medicines, when they need them, remains rock solid.